Net Loss Per Share - Schedule of Potential Shares of Common Stock (Details) |
12 Months Ended |
|---|---|
|
Dec. 31, 2025
shares
| |
| Schedule of Potential Shares of Common Stock [Line Items] | |
| Total anti-dilutive shares excluded | 159,477,800 |
| Series A convertible preferred shares [Member] | |
| Schedule of Potential Shares of Common Stock [Line Items] | |
| Total anti-dilutive shares excluded | 149,540,340 |
| Stock options [Member] | |
| Schedule of Potential Shares of Common Stock [Line Items] | |
| Total anti-dilutive shares excluded | 512,620 |
| Warrants [Member] | |
| Schedule of Potential Shares of Common Stock [Line Items] | |
| Total anti-dilutive shares excluded | 1,116,913 |
| PIPE convertible note [Member] | |
| Schedule of Potential Shares of Common Stock [Line Items] | |
| Total anti-dilutive shares excluded | 8,307,927 |